Valuation: Mayinglong Pharmaceutical Group Co., LTD.

Market Cap 1.03TCr 152.14Cr 133.35Cr 123.26Cr 113.36Cr 213.9Cr 15TCr 217.33Cr 1.47TCr 577.76Cr 7.18TCr 571.28Cr 558.82Cr 25TCr P/E 2026 *
15.3x
P/E 2027 * 12.7x
Enterprise Value 1.03TCr 152.14Cr 133.35Cr 123.26Cr 113.36Cr 213.9Cr 15TCr 217.33Cr 1.47TCr 577.76Cr 7.18TCr 571.28Cr 558.82Cr 25TCr EV / Sales 2026 *
2.39x
EV / Sales 2027 * 2.17x
Free-Float
64.65%
Yield 2026 *
-
Yield 2027 * -
1 day+0.89%
1 week+2.80%
Current month+10.55%
1 month+5.85%
3 months-3.47%
6 months-14.95%
Current year-14.64%
1 week 23.43
Extreme 23.43
24.69
1 month 21.22
Extreme 21.22
24.69
Current year 21.22
Extreme 21.22
29.22
1 year 21.22
Extreme 21.22
30.18
3 years 20.2
Extreme 20.2
31.46
5 years 17.99
Extreme 17.99
33.34
10 years 12.52
Extreme 12.52
33.54
Manager TitleAgeSince
Chief Executive Officer 48 28/05/2019
Director of Finance/CFO 49 28/12/2023
Corporate Officer/Principal 40 19/08/2021
Director TitleAgeSince
Chairman 64 16/03/2010
Director/Board Member 48 28/05/2019
Director/Board Member 40 14/06/2022
Change 5-day change 1-year change 3-year change Capi.($)
+0.89%+2.80%-14.95%-7.26% 150.65Cr
-1.71%-1.59%+52.60%+150.76% 1,05100Cr
-1.31%-3.05%+52.04%+48.41% 61TCr
-0.37%+2.11%+36.99%+78.09% 45TCr
-0.75%+0.30%+29.77%+21.15% 33TCr
-1.52%-1.19%+34.46%+35.35% 28TCr
-1.70%-1.82%+20.99%+15.74% 26TCr
-0.58%+1.11%-20.18%-40.59% 22TCr
-0.31%+1.34%+23.46%+56.62% 20TCr
-0.56%+1.69%+23.40%+67.14% 17TCr
Average -0.79%+0.42%+23.86%+42.54% 35.77TCr
Weighted average by Cap. -1.15%+0.02%+37.13%+72.02%

Financials

2026 *2027 *
Net sales 431.8Cr 64Cr 56Cr 52Cr 48Cr 90Cr 6.15TCr 91Cr 617.75Cr 242.16Cr 3.01TCr 239.44Cr 234.22Cr 10TCr 475.4Cr 70Cr 62Cr 57Cr 52Cr 99Cr 6.77TCr 100.29Cr 680.12Cr 266.61Cr 3.31TCr 263.62Cr 257.87Cr 11TCr
Net income 67Cr 9.95Cr 8.72Cr 8.06Cr 7.42Cr 14Cr 959.81Cr 14Cr 96Cr 38Cr 469.62Cr 37Cr 37Cr 1.62TCr 74Cr 11Cr 9.64Cr 8.91Cr 8.2Cr 15Cr 1.06TCr 16Cr 106.58Cr 42Cr 519.09Cr 41Cr 40Cr 1.79TCr
Net Debt - -
Logo Mayinglong Pharmaceutical Group Co., LTD.
Mayinglong Pharmaceutical Group Co Ltd is a China-based company mainly engaged in the production and sale of anorectal health products. The Company operates three segments. The Pharmaceutical Industry segment is mainly engaged in the development, production and sale of pharmaceuticals and health products. The Pharmaceutical Commerce segment is mainly engaged in the retail and wholesale of medical devices and pharmaceuticals. The Hospital Diagnosis and Treatment segment is mainly engaged in hospital medical services and management. The Company mainly conducts businesses within the domestic market.
Employees
2,544
Date Price Change Volume
20/26/20 CN¥23.90 +0.89% 94,65,655
17/26/17 CN¥23.69 -3.23% 93,64,235
16/26/16 CN¥24.48 +0.41% 1,09,30,092
15/26/15 CN¥24.38 +1.33% 84,27,800
14/26/14 CN¥24.06 -0.04% 88,80,000
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
23.90CNY
Average target price
36.25CNY
Spread / Average Target
+51.67%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 600993 Stock